The 81 rating InvestorsObserver gives to Marinus Pharmaceuticals Inc (MRNS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 95 percent of stocks in the Biotechnology industry, MRNS’s 81 overall rating means the stock scores better than 81 percent of all stocks.
MRNS has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on MRNS!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Marinus Pharmaceuticals Inc Stock Today?
Marinus Pharmaceuticals Inc (MRNS) stock has fallen -1.41% while the S&P 500 is up 0.41% as of 2:51 PM on Wednesday, Mar 6. MRNS has fallen -$0.13 from the previous closing price of $9.24 on volume of 934,657 shares. Over the past year the S&P 500 has gained 27.92% while MRNS is up 29.40%. MRNS lost -$2.63 per share the over the last 12 months.
Click Here to get the full Stock Report for Marinus Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
